How a US drugmaker contributed to the escalating drug shortage crisis
When Akorn Pharmaceuticals closed its doors in February, hospitals across the country felt it. The Lake Forest, Ill.-based drugmaker was responsible for producing 75 generic drugs, all of which were pulled from the market when the company closed. In some cases, the company was the sole supplier of particular products. The shutdown comes amid and … Read more
